The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Annual MeetingFull Access

Learn the Latest On Addiction Science

Published Online:https://doi.org/10.1176/pn.39.6.0037

APA’s 2004 annual meeting will include a special research-based program track presented in collaboration with the National Institute on Drug Abuse, titled “Integrating the Science of Addiction Into Psychiatric Practice.” This special track will raise awareness of new and emerging issues in addiction and psychiatry and provide important information related to best practices and treatment strategies. More information on the series is available by contacting Beatrice Eld Edner at (703) 907-8598 or .

Monday, May 3

9 a.m.-10:30 a.m.

    Lecture 2

    Signal Integration in the Brain

    Paul Greengard, Ph.D.

    Javits Center, Level 1, Rooms 1E07/8

    Issue Workshop 6

    Drug Abuse and Suicidal Behavior

    Chair: Eric D. Caine, M.D.

    Javits Center, Level 3, Room 3D02/11

    Issue Workshop 16

    Cocaine and Tobacco Use During Pregnancy: Adverse Outcomes in Offspring

    Chair: Vincent L. Smeriglio, Ph.D.

    Marriott Marquis, Seventh Floor, Empire/Hudson Rooms

11 a.m.-12:30 p.m.

    Issue Workshop 26

    Obtaining Research Funding From NIH: Keys to Successful Grant Writing

    Chair: Lucinda L. Miner, Ph.D.

    Marriott Marquis, Seventh Floor, Empire/Hudson Rooms

2 p.m.-5 p.m.

    Symposium 3

    Functional Brain Imaging of Addiction

    Chair: Elliot A. Stein, Ph.D.

    Javits Center, Level 1, Room 1E09

    Neuropsychiatric Implications of Mapping Reward/Aversion Circuitry

    Endogenous Opioid Neurotransmissions: Interfacing Reward and Stress Regulation

    Chronic Effects of Drug Use and HIV

    Neurobiological Substrates of Stimulant Action and Reward

    Symposium 4

    Treatment of Chronic Pain in Recovering Addicts

    Chair: Jag Khalsa, Ph.D.

    Javits Center, Level 1, Room 1E11

    Pain Assessment and Issues in Screening

    Assessing Aberrant Drug-Taking Behaviors in Medically Ill Patients With Pain

    The Development and Treatment of Opioid-Induced Hyperalgesia

    Prescribing Pain Medications for Recovering Addicts With Chronic Pain

    Principles of Pain Treatment in Addictive Disorders

    Symposium 22

    Obesity: Lessons Learned From Addiction

    Chair: Joseph Frascella, Ph.D.

    Discussant: Nora D. Volkow, M.D.

    Marriott Marquis, Seventh Floor, Empire/Hudson Rooms

    Genetic, Motivational, and Metabolic Factors Modulate the Neural Drive to Maintain Body Weight

    Cortico-Striatal-Hypothalamic Networks and Motivation for Food: Integration of Cognition, Reward, and Energy

    Food and Drug Cravings: Metaphor or Common Mechanism?

    Common and Diverging Neurobiological Features of Feeding and Drug Self-Administration in Humans

    Obesity and Addiction: Neuroimaging Studies

    Symposium 24

    Genetic and Environmental Factors Contributing to Vulnerability to Addiction

    Chair: Jonathan D. Pollock, Ph.D.

    Marriott Marquis, Ninth Floor, Cantor/Jolson Rooms

    Using Twin Data to Identify Alternative Drug-Abuse Phenotypes

    Common and Specific Genetic Factors in the Development of Substance Dependence

    Addiction Molecular Genetics: Remarkably Converging Results

    Using the Systems Biology of Motivation for Genetic Studies in Psychiatry

    Genetic and Environmental Factors Modulate Cocaine Abuse in Monkey Models

Tuesday, May 4

9 a.m.-10:30 a.m.

    Distinguished Psychiatrist Lecture 13

    Why Does the Human Brain Become Addicted?

    Nora D. Volkow, M.D.

    Javits Center, Level 1, Room 1E15

    Issue Workshop 45

    Steroid Abuse: Growing Problem for Adolescents and a Hidden Problem for Adults

    Chair: Donald R. Vereen, Jr, M.D.

    Marriott Marquis, Fifth Floor, Alvin/Carnegie Rooms

    Issue Workshop 48

    Emerging Pharmacotherapies for Treatment of Stimulant Dependence

    Chair: Francis J. Vocci, Ph.D.

    Marriott Marquis, Fifth Floor, Imperial/Julliard Rooms

    Issue Workshop 56

    Addiction Research as a Career Choice in Psychiatry

    Chairperson: Ivan D. Montoya, M.D.

    Marriott Marquis, Seventh Floor, Herald/Soho Rooms

9 a.m.-11 a.m.

    Research Advances in Medicine

    The Epidemiology and Treatment of Psychiatric Comorbidities

    Chair: Geetha Jayaram, M.D.

    Co-Chair: Joel J. Wallack, M.D.

    Javits Center, Level 1, Room 1E09

    Epidemiology of Comorbid Psychiatric and Addictive Disorders

    Comorbidity of Psychiatric and Addictive Disorders in Children

    Depression in Hepatitis C Patients and Interferon Treatment

    Research Advances in HIV Care

11 a.m.-12:30 p.m.

    Frontiers of Science Lecture 15

    Anticraving Medication: New Class of Psychoactive Medication?

    Charles P. O'Brien, M.D.

    Javits Center, Level 1, Room 1E15

    Issue Workshop 74

    Drugs and Other Addictions: Does One Size Fit All?

    Chair: Steven J. Grant, Ph.D.

    Marriott Marquis, Seventh Floor, Herald/Soho Rooms

    Issue Workshop 75

    Stress, Trauma, and Drug Abuse

    Chair: Nancy Pilotte, Ph.D.

    Marriott Marquis, Ninth Floor, Marquis Ballroom Salons A/B

2 p.m.-3:30 p.m.

    Frontiers of Science Lecture 18

    Conceptual and Methodological Flaws in the Evaluation of Addiction Treatment

    A. Thomas McLellan, Ph.D.

    Hilton New York, Third Floor, Trianon Ballroom

2 p.m.-5 p.m.

    Symposium 42

    Smoking and Comorbid Mental Disorders

    Chair: John R. Hughes, M.D.

    Javits Center, Level 3, Rooms 3D06/7

    Psychiatric Comorbidity of Smoking and Nicotine Dependence: An Epidemiologic Perspective

    The Neurobiology of Nicotine Dependence and Comorbid Psychiatric Disorders

    Nicotine-Dependence Treatment in Individuals With Schizophrenia

    Behavioral and Pharmacological Treatments for Smokers With Depression

    Symposium 55

    ADHD Subtypes and Subgroups at Risk for Substance Use Disorders

    Chair: Naimah Z. Weinberg, M.D.

    Marriott Marquis, Seventh Floor, Herald/Soho Rooms

    Subtypes of ADHD Youth At Risk for Substance Abuse

    Childhood ADHD, Comorbidity, and Risk for Late-Adolescent Drug Abuse

    Developmental Twin Studies of Relations Between Substance Use and ADHD

    Variability in Risk for Substance Use and Disorder Among Children Diagnosed With ADHD

    Behavioral and Cognitive Predictors of Adolescent Substance Use in Children With ADHD

    Long-Term Follow-Up of Childhood ADHD: Development of Adult Substance Abuse

Wednesday, May 5

9 a.m.-10:30 a.m.

    Issue Workshop 82

    Treatment of Patients With Drug Dependence and Psychiatric Illness

    Co-Chair: Roger D. Weiss, M.D.

    Co-Chair: Wilson Compton III, M.D.

    Javits Center, Level 1, Room 1E12

11 a.m.-12:30 p.m.

    Distinguished Psychiatrist Lecture 21

    Stress and Relapse to Substance Use Disorders

    Kathleen T. Brady, M.D.

    Javits Center, Level 1, Rooms 1E07/8

2 p.m.-5 p.m.

    Symposium 80

    Consequences and Treatment of Marijuana Abuse

    Chair: Susan R.B. Weiss, Ph.D.

    Co-Chair: Jag Khalsa, Ph.D.

    Marriott Marquis, Fifth Floor, Imperial/Julliard Rooms

    Cognitive Toxicity of Cannabis: The Devil Is in the Confounding Variables

    Cognitive Effects in Adolescents Exposed Prenatally to Marijuana or Cigarettes

    Effects of Chronic Marijuana Use and THC on Brain Function in Humans: A fMRI Study

    Behavioral and Treatment Research on Marijuana Withdrawal and Dependence

    The Endogenous Cannabinoids and the Control of Drug Craving

    Symposium 84

    Moving the Targets: The Neurobiology of Addiction

    Chair: Nancy Pilotte, Ph.D.

    Marriott Marquis, Seventh Floor, Columbia/Duffy Rooms

    Neuroadaptation in Addiction: The Extended Amygdala and Brain-Reward System

    Neural Circuitry of Relapse

    Drugs, Neuroplasticity, and Addiction

    How Do Drugs of Abuse Rewire the Motivational Circuitry?

    Symposium 85

    Drug Abuse Treatment Issues in Women

    Chair: Cora Lee Wetherington, Ph.D.

    Marriott Marquis, Seventh Floor, Empire/Hudson Rooms

    Gender Differences in Treatment Needs, Services, Utilization, and Outcomes

    Treatment Issues in Drug-Dependent Women With Comorbid Depression

    Trauma and PTSD: Issues in the Treatment of Drug-Dependent Women

    Drug-Dependent Women With Partner Violence: Treatment Issues

    Drug-Treatment Issues in Drug-Dependent, Pregnant Women

Thursday, May 6

2 p.m.-5 p.m.

    Symposium 96

    Behavioral Treatments for Drug Dependence

    Chair: Lisa S. Onken, Ph.D.

    Co-Chair: Bruce J. Rounsaville, M.D.

    Javits Center, Level 1, Room 1E13

    Durability of Cognitive-Behavioral Therapy Efficacy for Substance Abusers

    HIV Risk Reduction and Substance Abuse Treatment

    Low-Cost Contingency Management in Community Settings

    Cognitive-Behavioral Therapy and Naltrexone for Cocaine Dependence

    Behavioral Family Counseling and Naltrexone for Male, Opioid-Dependent Patients